Following the killing of George Floyd in June, medtech companies stood strongly against inequality and racism and promised to push for change. Boston Scientific’s executive committee, including CEO Michael Mahoney, issued one of the earliest statements to condemn “injustice and discrimination and to reaffirm our commitment to live by our values and cultivate a workplace […]
Farapulse
The top 5 MassDevice stories of the week — September 25, 2020
The past week in medtech saw Boston Scientific (NYSE:BSX) make an interesting move in the Afib space — and much more. Want to hear more about the week’s top news? Executive editor Chris Newmarker and Tom Salemi will discuss the week’s “Newmarker’s Newsmakers” during our DeviceTalks Weekly podcast. Without further ado, here’s this week’s MassDevice Top […]
Boston Scientific may buy Afib treatment startup Farapulse
Boston Scientific (NYSE:BSX) announced today that it signed an investment agreement with an option to acquire Farapulse. Menlo Park, Calif.-based Farapulse has developed a pulsed-field ablation (PFA) system for treating atrial fibrillation (Afib) and other cardiac arrhythmias. The PFA system is designed with a sheath, a generator and catheters to ablate heart tissue through a therapeutic […]
